Cyramza, also known by its generic name ramucirumab, is a medication that is commonly used in the treatment of certain types of cancer. It belongs to a class of drugs known as angiogenesis inhibitors, which work by blocking the growth of blood vessels that supply nutrients to tumors, thereby slowing down or stopping the growth of cancer cells.

Cyramza is often prescribed for patients with advanced gastric or gastroesophageal junction (GEJ) cancer, as well as non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It can be used alone or in combination with other chemotherapy medications, depending on the specific type and stage of cancer being treated.

As with any medication, Cyramza does come with potential side effects that should be discussed with your healthcare provider. Common side effects may include high blood pressure, fatigue, diarrhea, decreased appetite, and nausea. It is important to report any side effects to your healthcare provider promptly, as they may be able to provide guidance on managing or alleviating these symptoms.

It is crucial to follow your healthcare provider’s instructions carefully when taking Cyramza, including the recommended dosage and schedule for administration. It is also important to keep all follow-up appointments and laboratory tests as directed to monitor your response to the medication and any potential side effects.

Overall, Cyramza has shown promising results in the treatment of certain types of cancer and may be a valuable option for patients facing these diagnoses. If you have any questions or concerns about Cyramza or your treatment plan, do not hesitate to reach out to your healthcare provider for guidance and support.